MicroRNA-140-3p Represses the Proliferation, Migration, Invasion and Angiogenesis of Lung Adenocarcinoma Cells Via Targeting TYMS (thymidylate Synthetase)

Overview

Journal Bioengineered

Date 2021 Nov 25

PMID 34818974

Citations 9

Authors

Shanzhi Wan

Zhimin Liu

Yang Chen

Zhitao Mai

Mingming Jiang

Qingguo Di

Baohua Sun

Affiliations

Soon will be listed here.

Abstract

MicroRNA (miR)-140-3p has been proved to repress lung adenocarcinoma (LUAD), and our study aims to further evaluate the mechanism. Bioinformatic analyses were performed. The viability, proliferation, migration, invasion and angiogenesis of transfected LUAD cells were all determined via Cell Counting Kit-8, colony formation, Scratch, Transwell, and tube formation assays. The targeting relationship between miR-140-3p and thymidylate synthetase (TYMS) was confirmed by dual-luciferase reporter assay. Relative expressions of miR-140-3p, TYMS, epithelial-to-mesenchymal transition- (E-cadherin, N-cadherin, vimentin), angiogenesis- (vascular endothelial growth factor (VEGF)), and apoptosis-related factors (cleaved caspase-3, B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax)) were quantified by quantitative real-time polymerase chain reaction or Western blot. TYMS was high-expressed yet miR-140-3p was low-expressed in LUAD cells. Upregulation of miR-140-3p inhibited TYMS expression, viability, colony formation, migration, invasion, and tube length within LUAD cells, while downregulation of miR-140-3p did oppositely. Silenced TYMS, the downstream target gene of miR-140-3p, reversed the effects of miR-140-3p downregulation on TYMS expression, cell viability, colony formation, migration, invasion, and tube length as well as the metastasis-, apoptosis- and angiogenesis-related proteins in LUAD cells. Upregulation of miR-140-3p inhibited the proliferation, migration, invasion and angiogenesis of LUAD cells via targeting TYMS.

Citing Articles

Micro-RNA-140-3p Acts as a Tumor Suppressor Gene in Acute Promyelocytic Leukemia by Targeting Hepatocyte Growth Factor.

Lei R, Liu X, Wu Y, Song J, Lv X, Liu J Cell Biochem Biophys. 2025; .

PMID: 40057668 DOI: 10.1007/s12013-025-01707-4.

NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis.

Yun F, Wu N, Yi X, Zhang X, Feng Y, Ni Q Cell Death Dis. 2024; 15(10):720.

PMID: 39353904 PMC: 11445241. DOI: 10.1038/s41419-024-07104-8.

Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes endothelial cell angiogenesis by regulating the miR-140-3p/HIF-1α/VEGF signaling axis.

Payervand N, Pakravan K, Razmara E, Vinu K, Ghodsi S, Heshmati M Heliyon. 2024; 10(11):e31584.

PMID: 38828320 PMC: 11140710. DOI: 10.1016/j.heliyon.2024.e31584.

An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review.

Sen A, Karati D Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5437-5448.

PMID: 38446215 DOI: 10.1007/s00210-024-03020-y.

MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).

Liu J, Zhang F, Wang J, Wang Y Oncol Rep. 2023; 50(6).

PMID: 37859595 PMC: 10603552. DOI: 10.3892/or.2023.8648.

References

Lin G, Li H, Kuang J, Tang K, Guo Y, Han A . Acinar-Predominant Pattern Correlates With Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung. Am J Clin Pathol. 2018; 149(5):373-378. DOI: 10.1093/ajcp/aqx170. View

Greenawalt E, Edmonds M, Jain N, Adams C, Mitra R, Eischen C . Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion. Mol Cancer Res. 2018; 17(1):289-298. PMC: 6318035. DOI: 10.1158/1541-7786.MCR-18-0364. View

Rustum Y . Thymidylate synthase: a critical target in cancer therapy?. Front Biosci. 2004; 9:2467-73. DOI: 10.2741/1408. View

Xiong Y, Jin E, Yin Q, Che C, He S . Boron Attenuates Heat Stress-Induced Apoptosis by Inhibiting Endoplasmic Reticulum Stress in Mouse Granulosa Cells. Biol Trace Elem Res. 2020; 199(2):611-621. DOI: 10.1007/s12011-020-02180-1. View

Wang Z, Embaye K, Yang Q, Qin L, Zhang C, Liu L . Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Cancer Cell Int. 2021; 21(1):219. PMC: 8050921. DOI: 10.1186/s12935-021-01915-x. View

Folkman J . Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2003; 29(6 Suppl 16):15-8. DOI: 10.1053/sonc.2002.37263. View

Lu T, Rothenberg M . MicroRNA. J Allergy Clin Immunol. 2017; 141(4):1202-1207. PMC: 5889965. DOI: 10.1016/j.jaci.2017.08.034. View

Kloosterman W, Plasterk R . The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11(4):441-50. DOI: 10.1016/j.devcel.2006.09.009. View

Feitelson M, Arzumanyan A, Kulathinal R, Blain S, Holcombe R, Mahajna J . Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015; 35 Suppl:S25-S54. PMC: 4898971. DOI: 10.1016/j.semcancer.2015.02.006. View

10.

Ma J, Zhang F, Sun P . miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis. Bioorg Med Chem. 2020; 28(3):115283. DOI: 10.1016/j.bmc.2019.115283. View

11.

Ferrari S, Severi L, Pozzi C, Quotadamo A, Ponterini G, Losi L . Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth. Vitam Horm. 2018; 107:473-513. DOI: 10.1016/bs.vh.2017.12.002. View

12.

Denisenko T, Budkevich I, Zhivotovsky B . Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018; 9(2):117. PMC: 5833343. DOI: 10.1038/s41419-017-0063-y. View

13.

Francescone 3rd R, Faibish M, Shao R . A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. J Vis Exp. 2011; (55). PMC: 3230200. DOI: 10.3791/3040. View

14.

Tirapelli D, Lustosa I, Menezes S, Franco I, Rodrigues A, Peria F . High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas. Arq Neuropsiquiatr. 2017; 75(12):875-880. DOI: 10.1590/0004-282X20170156. View

15.

Fu F, Zhang Y, Gao Z, Zhao Y, Wen Z, Han H . Development and validation of a five-gene model to predict postoperative brain metastasis in operable lung adenocarcinoma. Int J Cancer. 2020; 147(2):584-592. DOI: 10.1002/ijc.32981. View

16.

Ntavatzikos A, Spathis A, Patapis P, Machairas N, Vourli G, Peros G . TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World J Gastrointest Oncol. 2019; 11(7):551-566. PMC: 6657223. DOI: 10.4251/wjgo.v11.i7.551. View

17.

Yerukala Sathipati S, Ho S . Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles. Sci Rep. 2017; 7(1):7507. PMC: 5548864. DOI: 10.1038/s41598-017-07739-y. View

18.

Taddia L, DArca D, Ferrari S, Marraccini C, Severi L, Ponterini G . Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance. Drug Resist Updat. 2015; 23:20-54. DOI: 10.1016/j.drup.2015.10.003. View

19.

Mrozik K, Blaschuk O, Cheong C, Zannettino A, Vandyke K . N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer. 2018; 18(1):939. PMC: 6167798. DOI: 10.1186/s12885-018-4845-0. View

20.

Kunita A, Morita S, Irisa T, Goto A, Niki T, Takai D . MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression. Sci Rep. 2018; 8(1):8838. PMC: 5995955. DOI: 10.1038/s41598-018-27128-3. View